Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Esomeprazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel titanium-catalyzed oxidation method ensures high purity esomeprazole intermediates with scalable industrial production capabilities for global supply chains.
Patent CN107400118B reveals an optimized synthesis for esomeprazole intermediate mufelazole, offering improved purity and simplified workup for reliable pharma intermediates supply.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Novel preparation method controls water content below 0.03%. Enhances oxidation selectivity and yield for esomeprazole manufacturing.